TRIMACARE, India's first prenatal pregnancy supplement based on the Multi-Micronutrientmodel (MMN), has been granted a patent, heralding a new era in prenatal care and marking a significant milestone in the vast Indian pregnancy market.
India, with one of the world's largest populations, presentsan immense pregnancy market. Despite this, the prenatal supplement industry has remained primarily dominated by iron and calcium supplements for decades. The patent grant to TRIMACARE signifies a paradigm shift, making it the first supplement in India that caters specifically to the unique needs of each trimester of pregnancy.
Developed by co-founders Sameer Agarwal and Surbhi Gupta,TRIMACARE replaces the prevalent Iron-Folate-Calcium model with an advanced MMN approach. The result is a prenatal supplement that supports optimal brain development, organ growth, and weightgain in babies and robust maternal health.
